Skip to main content
CORT
NASDAQ Life Sciences

Q3 Revenue Jumps 64% to $340.5M as Lifyorli Launch Accelerates; Guidance Reiterated

Tom Rudovsky · Reported by BusinessWire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$81.93
Mkt Cap
$8.857B
52W Low
$28.66
52W High
$126.383
52W Position info
186% above low
Off High info
35% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

CORT has more than doubled off its 52-week low of $28.66.

Summary

Corcept delivered a big step-up in Q3: revenue of $340.5M versus $256.1M in Q2, with net income of $126.8M versus $43.0M the prior quarter and EPS of $1.01. Lifyorli, launched April 1st, brought in $91.4M, up 92% sequentially, and management says more than 2,300 patients and 1,700 prescribers are already on board. Korlym and authorized generic revenue rose 19% to $249.1M, and the company reiterated 2026 revenue guidance of $1.1-$1.2 billion. Cash and investments grew to $662.3M from $544.6M at June 30, even after $43.7M of buybacks. The pipeline added two items: MONARCH MASH data showed 19% fibrosis improvement at 48 weeks with a higher-dose Phase 2 starting soon, and DAZALS ALS exploratory analyses showed an 84% reduction in risk of death in year one, with a Phase 3 planned for next year. The nearest hard catalyst is the FDA's December 17, 2026 PDUFA decision on relacorilant for Cushing's syndrome.

At the time of this announcement, CORT was trading at $81.93 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $8.9B. The 52-week trading range was $28.66 to $126.38. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

CORT - Latest Insights

CORT
Nov 03, 2026, 4:11 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $78.50
Real-time Price: $63.02 info
Change: -$15.48 (-20%) info
Market Cap: $6.9B info
CORT
Oct 26, 2026, 8:00 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $86.01
Real-time Price: $63.02 info
Change: -$22.99 (-27%) info
Market Cap: $6.9B info
CORT
Oct 20, 2026, 4:00 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $116.51
Real-time Price: $63.02 info
Change: -$53.48 (-46%) info
Market Cap: $6.9B info
CORT
Sep 18, 2026, 8:00 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $114.90
Real-time Price: $63.02 info
Change: -$51.88 (-45%) info
Market Cap: $6.9B info
CORT
Jul 29, 2026, 4:09 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $112.56
Real-time Price: $63.02 info
Change: -$49.54 (-44%) info
Market Cap: $6.9B info